382 related articles for article (PubMed ID: 25916569)
41. Should Single-Coil Implantable Cardioverter Defibrillator Leads Be Used in all Patients?
Almehmadi F; Manlucu J
Card Electrophysiol Clin; 2018 Mar; 10(1):59-66. PubMed ID: 29428142
[TBL] [Abstract][Full Text] [Related]
42. Transvenous extraction profile of Riata leads: procedural outcomes and technical complexity of mechanical removal.
Bongiorni MG; Di Cori A; Segreti L; Zucchelli G; Viani S; Paperini L; De Lucia R; Levorato D; Boem A; Soldati E
Heart Rhythm; 2015 Mar; 12(3):580-587. PubMed ID: 25499627
[TBL] [Abstract][Full Text] [Related]
43. PR interval identifies clinical response in patients with non-left bundle branch block: a Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy substudy.
Kutyifa V; Stockburger M; Daubert JP; Holmqvist F; Olshansky B; Schuger C; Klein H; Goldenberg I; Brenyo A; McNitt S; Merkely B; Zareba W; Moss AJ
Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):645-51. PubMed ID: 24963007
[TBL] [Abstract][Full Text] [Related]
44. Patient, physician, and procedural factors influencing the use of defibrillation testing during initial implantable cardioverter defibrillator insertion: findings from the NCDR®.
Russo AM; Wang Y; Al-Khatib SM; Curtis JP; Lampert R
Pacing Clin Electrophysiol; 2013 Dec; 36(12):1522-31. PubMed ID: 23981009
[TBL] [Abstract][Full Text] [Related]
45. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
[TBL] [Abstract][Full Text] [Related]
46. Long-term complications, reoperations and survival following cardioverter-defibrillator implant.
Hawkins NM; Grubisic M; Andrade JG; Huang F; Ding L; Gao M; Bashir J
Heart; 2018 Feb; 104(3):237-243. PubMed ID: 28747313
[TBL] [Abstract][Full Text] [Related]
47. Generator replacement is associated with an increased rate of ICD lead alerts.
Lovelock JD; Cruz C; Hoskins MH; Jones P; El-Chami MF; Lloyd MS; Leon A; DeLurgio DB; Langberg JJ
Heart Rhythm; 2014 Oct; 11(10):1785-9. PubMed ID: 24953380
[TBL] [Abstract][Full Text] [Related]
48. Implantable intravascular defibrillator: defibrillation thresholds of an intravascular cardioverter-defibrillator compared with those of a conventional ICD in humans.
Neuzil P; Reddy VY; Merkely B; Geller L; Molnar L; Bednarek J; Bartus K; Richey M; Bsee TJ; Sanders WE
Heart Rhythm; 2014 Feb; 11(2):210-5. PubMed ID: 24144885
[TBL] [Abstract][Full Text] [Related]
49. Dual-coil vs single-coil active pectoral implantable defibrillator lead systems: defibrillation energy requirements and probability of defibrillation success at multiples of the defibrillation energy requirements.
Schulte B; Sperzel J; Carlsson J; Schwarz T; Ehrlich W; Pitschner HF; Neuzner J
Europace; 2001 Jul; 3(3):177-80. PubMed ID: 11467457
[TBL] [Abstract][Full Text] [Related]
50. Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
Borne RT; Peterson PN; Greenlee R; Heidenreich PA; Wang Y; Curtis JP; Tzou WS; Varosy PD; Kremers MS; Masoudi FA
Circulation; 2014 Sep; 130(10):845-53. PubMed ID: 25095884
[TBL] [Abstract][Full Text] [Related]
51. [Parameters of cardiac pacing and effectiveness of defibrillation during implantable cardioverter-defibrillator lead implantation to right ventricle outflow tract].
Rydlewska A; Machejek J; Engel A; Lelakowski J
Pol Merkur Lekarski; 2013 Nov; 35(209):254-8. PubMed ID: 24575643
[TBL] [Abstract][Full Text] [Related]
52. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.
Kolb C; Sturmer M; Sick P; Reif S; Davy JM; Molon G; Schwab JO; Mantovani G; Dan D; Lennerz C; Borri-Brunetto A; Babuty D
JACC Heart Fail; 2014 Dec; 2(6):611-9. PubMed ID: 25282033
[TBL] [Abstract][Full Text] [Related]
53. Single and dual coil shock efficacy and predictors of shock failure in patients with modern implantable cardioverter defibrillators-a single-center paired randomized study.
Larsen JM; Heath FP; Riahi S; Holm K; Johansen MB; Hjortshøj SP; Thøgersen AM
J Interv Card Electrophysiol; 2019 Jan; 54(1):65-72. PubMed ID: 30229405
[TBL] [Abstract][Full Text] [Related]
54. The azygos defibrillator lead for elevated defibrillation thresholds: implant technique, lead stability, and patient series.
Cooper JA; Latacha MP; Soto GE; Garmany RG; Gleva MJ; Chen J; Faddis MN; Smith TW
Pacing Clin Electrophysiol; 2008 Nov; 31(11):1405-10. PubMed ID: 18950297
[TBL] [Abstract][Full Text] [Related]
55. Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure.
Hauser RG; Hayes DL
Heart Rhythm; 2009 May; 6(5):605-10. PubMed ID: 19285920
[TBL] [Abstract][Full Text] [Related]
56. Troponin levels after ICD implantation with and without defibrillation testing and their predictive value for outcomes: Insights from the SIMPLE trial.
Vamos M; Healey JS; Wang J; Duray GZ; Connolly SJ; van Erven L; Vinolas X; Neuzner J; Glikson M; Hohnloser SH
Heart Rhythm; 2016 Feb; 13(2):504-10. PubMed ID: 26569461
[TBL] [Abstract][Full Text] [Related]
57. Risk of failure of transvenous implantable cardioverter-defibrillator leads.
Borleffs CJ; van Erven L; van Bommel RJ; van der Velde ET; van der Wall EE; Bax JJ; Rosendaal FR; Schalij MJ
Circ Arrhythm Electrophysiol; 2009 Aug; 2(4):411-6. PubMed ID: 19808497
[TBL] [Abstract][Full Text] [Related]
58. Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy.
Biton Y; Moss AJ; Kutyifa V; Mathias A; Sherazi S; Zareba W; McNitt S; Polonsky B; Barsheshet A; Brown MW; Goldenberg I
Circ Heart Fail; 2015 Sep; 8(5):921-6. PubMed ID: 26179186
[TBL] [Abstract][Full Text] [Related]
59. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2.
Sacher F; Probst V; Maury P; Babuty D; Mansourati J; Komatsu Y; Marquie C; Rosa A; Diallo A; Cassagneau R; Loizeau C; Martins R; Field ME; Derval N; Miyazaki S; Denis A; Nogami A; Ritter P; Gourraud JB; Ploux S; Rollin A; Zemmoura A; Lamaison D; Bordachar P; Pierre B; Jaïs P; Pasquié JL; Hocini M; Legal F; Defaye P; Boveda S; Iesaka Y; Mabo P; Haïssaguerre M
Circulation; 2013 Oct; 128(16):1739-47. PubMed ID: 23995538
[TBL] [Abstract][Full Text] [Related]
60. High defibrillation threshold in patients with implantable defibrillator: how effective is the subcutaneous finger lead?
Osswald BR; De Simone R; Most S; Tochtermann U; Tanzeem A; Karck M
Eur J Cardiothorac Surg; 2009 Mar; 35(3):489-92. PubMed ID: 19144533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
